Coronavirus: Commission offers financing to innovative vaccines company CureVac

covid19

(CDC, Unsplash)

This article is brought to you in association with the European Commission.


Today, the Commission offered up to €80 million of financial support to CureVac, a higly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe. Commission President Ursula von der Leyen and Commissioner for Innovation, Research, Culture, Education and Youth, Mariya Gabriel, discussed with the CureVac management via videoconference. The Vice-President of the European Investment Bank (EIB), Ambroise Fayolle, also participated. The support would come in form of an EU guarantee of a currently assessed EIB loan of an identical amount, in the framework of the InnovFin Infectious Disease Finance Facility under Horizon 2020.

Commission President Ursula von der Leyen said: “In this public health crisis it is of utmost importance that we support our leading researchers and tech companies. We are determined to provide CureVac with the financing it needs to quickly scale up development and production of a vaccine against the Coronavirus. I am proud that we have leading companies like CureVac in the EU. Their home is here. But their vaccines will benefit everyone, in Europe and beyond.”

Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: “Supporting excellent EU research and innovation is an essential part of our coordinated response against the spread of the Coronavirus. In 2014, CureVac won EU’s first ever innovation inducement prize. We are committed to support further its EU-based research and innovation in these critical times. Science and innovation in Europe are at the heart of our policies for protecting people’s health.”

Ambroise Fayolle, Vice-President for Innovation in the European Investment Bank, said: “The EIB is and remains the EU Bank for innovation, even more than ever in the current health crisis. Thanks to our strong and fruitful long partnership with the Commission in the area of research and innovation financial instruments (InnovFin), we are determined to do our best to support CureVac scale up needs for the benefits of EU citizen and beyond.”   

Founded in 2000, CureVac is a German biopharmaceutical company that has developed a novel technology to overcome one of the biggest barriers to using vaccines: the need to keep them stable without refrigeration. Its vaccine technology is based on messenger RNA (mRNA) molecules that stimulate the immune system. Preliminary studies have shown that the technology holds a promise for rapid response to COVID-19. If proven, millions of vaccine doses could potentially be produced at low costs in existing CureVac production facilities. CureVac has already started its COVID-19 vaccine development program and estimates to launch clinical testing by June 2020.

The Commission recognised CureVac’s potential to bring life-saving vaccines to people across the planet in safe and affordable ways already in 2014 when CureVac received the first ever EU innovation inducement prize of €2 million, funded by the EU’s research and innovation programme, FP7. The award was intended to support further development of the breakthrough idea. Now the Commission and the EIB are strengthening jointly their efforts to provide the necessary means to CureVac, taking advantage of their long and fruitful cooperation in financial instruments dedicated to support research and innovation such as Horizon 2020 InnovFin and in particular its Infectious Disease Finance Facility.

Background

The support to CureVac is part of coordinated EU response to the public health threat of COVID-19.

Working closely with the industry, the Commission has mobilised up to €140 million in public and private funding to support urgently needed research. On 6 March, the Commission announced that it selected 17 projects involving 136 research teams to receive a total funding of €47.5 million from its research and innovation programme, Horizon 2020. The teams will work on developing vaccines, new treatments, diagnostic tests and medical systems aimed at preventing the spread of the Coronavirus. In addition, the Commission has committed up to €45 million for research on vaccines and treatments through a call published on 3 March by the Innovative Medicines Initiative (IMI), which is to be matched by the pharma industry, so up to €90 million in all.

In the past years the European Commission has invested greatly in research to prepare exactly for this type of public health emergency. Several EU funded projects are currently contributing to the European and global preparedness and response activities.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

EU job-search aid worth €2 million for 500 former shipbuilding workers in Spain

India’s economy is growing fast, but its poorest areas lag behind. Here’s why this could be about to change

Future of EU farming: MEPs push for modern common policy with fair funding

3 ways firms can master the digital challenges of the 4IR

Embracing the diversity in a multicultural city of Romania

The role of medical students in promoting women’s rights

Venezuela: European Parliament calls for additional sanctions

UN highlights importance of skills development on World Youth Skills Day

Inflation down to 0.7%, unemployment up at 12.2%: Bad omens for Eurozone

Employment and Social Developments in Europe review: why social fairness and solidarity are more important than ever

17 ways technology could change the world by 2025

Human health – litmus paper for the climate change?

Mozambique cyclones a ‘wake-up call’ to boost resistance: UN weather agency

UN human rights chief regrets closure of Burundi office following Government pressure

After the Italian ‘no’ and the Brexit, Germans must decide which Europe they want

“Decisions taken in the coming weeks will shape Europe’s experience of the internet”, Joe Mcnamee from EDRi says live from European Business Summit 2015

Here are what UNESCO considers to be remarkable new World Heritage Sites

Coronavirus: Commission lists key steps for effective vaccination strategies and vaccines deployment

Cyprus President urges collective leadership to address ‘root causes’ of world’s crises

End ‘cycle of violence’ in Gaza, UN deputy chief tells forum on Palestine

Pedal power makes ‘positive impact on climate’, urges UN on World Bicycle Day

Historian Niall Ferguson on what the pandemic means for the global economy, geopolitics – and parties

UN underscores the need to celebrate indigenous peoples, not confine them

What is the Coral Triangle?

Asylum seekers in Sri Lanka fear for their safety, in wake of Easter Sunday terror attacks

This warehouse is one of the world’s greenest industrial buildings

EU and 15 World Trade Organization members establish contingency appeal arrangement for trade disputes

Greta Thunberg at #DavosAgenda: Here’s how climate experts responded to her speech

Statement by OECD Secretary-General Angel Gurría on the outcome of COP 25

Deepfake democracy: Here’s how modern elections could be decided by fake news

Why leaders need to upgrade their operating systems

The New Year 2016 will not be benevolent to Europe

Trump reshapes the Middle East at the expenses of Europe

MEPs want to boost energy storage in the EU to help spur decarbonisation

A refugee from Syria cries out: “I’m not just a number!”

Companies can help solve water scarcity. Here’s how

Building trust: Here’s what you need to know about The Davos Agenda 2021

Italy’s dilemma after Merkel-Hollande agreed loose banking union

Global Trade Identity can be the cornerstone of paperless trade

Coronavirus: a cultural escape goat or the next Big Five

8 fascinating and fearsome frontiers of science you should know about

South Africa’s cabinet is now 50% women for the first time ever

Brazil must immediately end threats to independence and capacity of law enforcement to fight corruption

Release of prize-winning Reuters journalists in Myanmar welcomed by UN

EU approves close to €240 million to strengthen resilience in neighbouring countries hosting Syrian refugees in light of the coronavirus pandemic

UN urges ‘maximum restraint’ as Israel-Hamas tensions rise over rocket attack

WhatsApp to face scrutiny from EU regulators task force over data sharing with Facebook

Climate change: What is COP26 and why does it matter?

Asylum: MEPs call for more solidarity among EU member states

How to build a digital infrastructure that benefits emerging economies

Here’s how businesses can make the circular economy a reality

5 ways students can graduate fully qualified for the Fourth Industrial Revolution

What is behind the wide reach of  fake news about Coronavirus?

Telemedicine in Brazilian favelas: The medicine of social isolation transforming public health

The Commission breathless behind the horsemeat scandal

COVID-19 is a threat to waste pickers. Here’s how to help them

World Migratory Bird Day highlights deadly risks of plastic pollution

Rohingya emergency one year on: UN says thousands of lives saved, but challenges remain

5 amazing schools that will make you wish you were young again

4 ways to build a net-zero economy by 2050

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s